Generalized linear mixed modeling showed a shorter duration of upper respiratory symptoms in the probiotic group than in the placebo group ( mean SD : 6.4 6.1 vs. 7.3 9.7 d , P = 0.0059 ) in the last 3 wk of the intervention period .